EDITORIAL COMMENTARIES
The apolipoprotein-
4 gene: always harmful?
Correspondence to:
T W Teasdale, Department of Psychology, University of Copenhagen, Øster Farimagsgade 5, 1353 Copenhagen K, Denmark; tom.teasdale@psy.ku.dk
| The first 150 words of the full text of this article appear below. |
It has now long been established that the apolipoprotein epsilon 4 allele (APOE-
4) on chromosome 19 constitutes a genetic risk factor for the development of Alzheimers disease.1 Since that discovery, APOE-
4 has also often been implicated as being harmful in acquired types of brain injury including traumatic injury2 at least in the short term. Willemse-van Son et als evidence (see page 10.1136/jnnp.2007.129460) is reported to suggest, however, that APOE-
4 can be associated with better, not worse, outcome following traumatic brain injury.3
What is distinctive in the design of their careful study is, first, that they followed traumatic brain injury patients up to 3 years post injury and, second, that they used a broad measure of outcome functioning. Their striking finding is that a group of patients carrying APOE-
4 had, in the long term, a significantly better outcome, as measured by the Glasgow Outcome
Relevant Article
-
Association between apolipoprotein-
4 and long-term outcome after traumatic brain injury
- A H P Willemse-van Son, G M Ribbers, W C J Hop, C M van Duijn, H J Stam
J. Neurol. Neurosurg. Psychiatry 2008 79: 426-430.[Abstract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
